RESEARCH ALERT-UBS cuts Idenix price target

Oct 12 (Reuters) - :

* UBS cuts Idenix price target to $9 from $10

* UBS raises Celgene price target to $82 from $80

* UBS raises Biogen price target to $160 from $156 For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Newsroom; [phone]))